Mirlinda Biba

Years Active: 2021-2023
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Jeffrey T Kuethe, Joshua Lee, David A Thaisrivongs, Nobuyoshi Yasuda, Scott R Pollack, Joseph Leone, Jimmy O DaSilva, Mirlinda Biba, Fuh-Rong Tsay, Erik L Regalado, Ji Qi, Hongming Li, Guilherme Dal Poggetto, Ryan D Cohen
Synthesis of a Complex and Highly Potent PCSK9 Inhibitor. Organic letters (2023)
Gregory L Adams, Parul S Pall, Steven M Grauer, Xiaoping Zhou, Jeanine E Ballard, Marissa Vavrek, Richard L Kraus, Pierre Morissette, Nianyu Li, Stefania Colarusso, Elisabetta Bianchi, Anandan Palani, Rebecca Klein, Christopher T John, Deping Wang, Matthew Tudor, Andrew F Nolting, Mirlinda Biba, Timothy Nowak, Alexey A Makarov, Mikhail Y Reibarkh, Alexei V Buevich, Wendy Zhong, Erik L Regalado, Xiao Wang, Qi Gao, Aurash Shahripour, Yuping Zhu, Daniele de Simone, Tommaso Frattarelli, Nicolo' Maria Pasquini, Paola Magotti, Roberto Iaccarino, Yuxing Li, Kelli Solly, Keun-Joong Lee, Weixun Wang, Feifei Chen, Haoyu Zeng, Jixin Wang, Hilary Regan, Rupesh P Amin, Christopher P Regan, Christopher S Burgey, Darrell A Henze, Chengzao Sun, David M Tellers
Development of ProTx-II Analogues as Highly Selective Peptide Blockers of Na v 1.7 for the Treatment of Pain. Journal of medicinal chemistry 65 (1) (2021)

Mirlinda Biba.css-eqlu8i{font-size:small;padding-left:4px;}